Per the Centers for Disease Control and Prevention (CDC), using NHANES 2017March 2020 data, 41.9% of US adults have obesity (BMI 30) the population for whom compounded GLP-1 telehealth was built
These supplements also include a small amount of gelatin, but the source is not indicated
Semaglutide is a GLP-1 receptor agonist medication, and as it has undergone significant testing and studies in order to be approved as a Type II Diabetes and weight loss treatment, it is considered relatively safe
The fact that some people see results early is because their body have absorbed the components well
Lillys Retatrutide: Toward the End of Incremental Metabolic Medicine Why GLP-1++ therapies are redefining what is worth developing and what is not In early December 2025, Eli Lilly announced landmark Phase 3 results for retatrutide its investigational once-weekly triple hormone receptor agonist targeting GLP-1, GIP, and glucagon